Clinical research represents the tools to explore and, more importantly, to validate the utility of medical treatments and strategies. Clinical trials include very different designs and require very different levels of infrastructure depending on the question they address. For example, trials testing new drugs or new devices usually require a high level of infrastructure and, therefore, present a high cost per patient. Nevertheless, trials testing strategies and treatment combinations of already approved drugs require a low level of infrastructure and data collection.
These late trials, could be called « real life trials » as they:
- test questions related to daily practices in oncology
- do not require specific infrastructure
- require a minimal amount of data collection
- impact millions of patients worldwide.
Paradoxically, these trials do not usually find funding to be run despite having a very low cost.
The Gustave Roussy Foundation and CRIS Cancer Foundation have a rationale to develop a new generation of practice-changing or practice-informing trials. For this reason, we are calling for applications to their Real-Life Trials in Oncology Programme to support the development of practice-changing clinical trials in France and Spain.
The evaluation process of the 2023 Call for Real Life Trials in Oncology has been completed.
The final resolution can be downloaded at the following link.
2023 RLTiO Awards Certificate Descarga
The evaluation process of the 2022 Call for Real Life Trials in Oncology has been completed.
The final resolution can be downloaded at the following link